Annual Report & Accounts for the year ended 30 June 2016

our global growth Strategy

Click here to view more on Strategic Report

our global growth strategy

Click here to view more on Delivering Our Strategy

Our approach
to Governance which enhances shareholder value

Click here to view more on Our Governance

financial performance

Click here to view more on Our Financials

Chairman's and Chief Executive Officer's Statement

View the statement

Total Revenue


2015: £203.5m

CER*: Up 21.7%

£: Up 21.7%

Underlying Operating Profit


2015: £44.4m

CER*: Up 20.9%

£: Up 19.1%

Underlying Diluted Earnings per Share


2015: 39.90p

CER*: Up 8.9%

£: Up 6.9%

Dividend per Share


2015: 16.94

CER*: Up 9.0%

£: Up 9.0%

Reported Operating Profit


2015: £26.0m

CER*: Down (17.3%%)

£: Down (25.0%)

Diluted Reported Earnings per Share


2015: 21.99p

CER*: Down (28.9%)

£: Down (36.8%)

View our highlights


with Ian Page

Watch the video

Our Business Model

View the business model

Product Development

View product development

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide.

Corporate Social Responsibility

View our CSR report

Our Geographical Footprint

map View our geographical footprint

Key Products



Dermatology and care

Dermatology and Care

Anaesthesia and Analgesia

Anaesthesia and Analgesia

Cardiovascular Disease

Cardiovascular Disease



Equine Medicine

Equine Medicine

Food producing Animal Products

Food producing Animal Products

Pet Diets

Pet Diets

Poultry Vaccines

Poultry Vaccines

View our key products